See both the conservative case and full opportunity, built on published data and validated screening economics.
Projections based on: dementia prevalence 15% of 65+ (Alzheimer's Association 2024); undiagnosed rate 67% (Lang et al. 2017 BMJ Open, Amjad et al. 2018 JGIM); screening completion 63%; patient completion 91%; full battery trigger ~20% (6CIT cutoff); RAF per diagnosis $3K–$6K (CMS-HCC V28); crisis cost $8,400/event (Lin et al. 2021); CPT 99483 $282; CCM $504/yr; 6CIT validated across 6,783 patients (>82% sensitivity, >87% specificity).
Average ACO size: CMS PY 2024 MSSP data (476 ACOs, 10.8M beneficiaries). All figures are projections; actual results vary by population demographics, payer mix, and coding maturity.
This calculator uses population-level estimates. Our value assessment models your actual patient demographics, payer mix, and current screening patterns. 20 minutes. The model is yours to keep.
We use cookies to improve user experience. Choose what cookie categories you allow us to use. You can read more about our Cookie Policy by clicking on Cookie Policy below.
These cookies enable strictly necessary cookies for security, language support and verification of identity. These cookies can’t be disabled.
These cookies collect data to remember choices users make to improve and give a better user experience. Disabling can cause some parts of the site to not work properly.
These cookies help us to understand how visitors interact with our website, help us measure and analyze traffic to improve our service.
These cookies help us to better deliver marketing content and customized ads.